Cytori Therapeutics, Inc. / Agreement/Capital Increase
29.03.2007
Release of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Cytori Therapeutics, Inc. (NASDAQ: CYTX; Frankfurt: XMPA) entered into a
strategic equity agreement with Green Hospital Supply, Inc. (TYO: 3360),
one of the leading medical equipment suppliers in Japan, who will purchase
1.0 million shares of Cytori common stock at $6.00 per share. The
transaction will close on or about April 12, 2007, subject to satisfaction
of customary closing conditions.
'With this equity position in Cytori, Green Hospital Supply is making its
first strategic investment in the emerging field of regenerative medicine,'
said Mr. Kunihisa Furukawa, President of Green Hospital Supply. 'We have
the required infrastructure and consulting experience to effectively
provide and integrate certain regenerative medicine technologies, which may
include cell preservation services, to medical centers throughout Japan.'
'This deal bolsters our cash position, adds another strategic financial
partner who shares our vision for regenerative medicine, and allows us to
maintain our focus on the development of therapeutic applications for the
Celution(TM) System and its near-term launch in Europe,' said Christopher J.
Calhoun, chief executive officer of Cytori Therapeutics. 'We have jointly
identified future collaborative opportunities, which we look forward to
further exploring.'
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
About Green Hospital Supply, Inc.
Green Hospital Supply, Inc. (TYO: 3360) operates three businesses, which
offer one-stop solutions for medical institutions in Japan to optimize
their hospital management. The Total Pack System business offers solutions
to meet the needs of clients to open, relocate, add and/or renovate
hospital facilities. Green Hospital Supply continues the client
relationships by selling medical practice materials and consumables after
hospitals start operations (Medical Supply Business), and supplying meals
and medical-related services (Health Care Business). The Company
strengthens ties with its clients by making them business partners to
further expand the spectrum of businesses, for example, launching
dispensing pharmacies near hospitals (Health Care Business).
http://www.ghs-inc.co.jp
About Cytori Therapeutics
Cytori Therapeutics is developing and seeks to commercialize stem and
regenerative cell therapies for cardiovascular disease, reconstructive
surgery and many other serious chronic, and life threatening conditions. To
provide these therapies, physicians remove a small amount of a patient's
fat, also known as adipose tissue, and run it through Cytori's Celution(TM)
System. This System quickly separates and concentrates stem and
regenerative cells from adipose tissue so they may be quickly administered
back to the patient about an hour later. This system will dramatically
improve the way in which personalized cell-based therapies can be delivered
to patients. www.cytoritx.com
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking statements regarding events,
trends and prospects of our business, which may affect our future operating
results and financial position. Such statements are subject to risks and
uncertainties that could cause our actual results and financial position to
differ materially. Some of these risks and uncertainties include our
history of operating losses, the need for further financing, regulatory
uncertainties, dependence on performance of third parties, and other risks
and uncertainties described (under the heading 'Risk Factors') in Cytori
Therapeutics' Form 10-K annual report for the year ended December 31, 2005
and subsequent SEC filings. We assume no responsibility to update or revise
any forward-looking statements to reflect events, trends or circumstances
after the date they are made.
DGAP 29.03.2007
---------------------------------------------------------------------------
Language: English
Issuer: Cytori Therapeutics, Inc.
6740 Top Gun Street
92121 San Diego, CA Vereinigte Staaten von Amerika
Phone: 001-858 / 736 5485
Fax: 001-858 / 458 0994
E-mail: sbacher@cytoritx.com
www: www.cytoritx.com
ISIN: US23283K1051
WKN: A0ETV6
Indices: PRIMEALL, TECHALLSHARE
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin-Bremen, Stuttgart, München, Düsseldorf
End of News DGAP News-Service
---------------------------------------------------------------------------